Induction of postsurgical tumor immunity and T-cell memory by a poorly immunogenic tumor

P Zhang, AL Côté, VC de Vries, EJ Usherwood… - Cancer research, 2007 - AACR
P Zhang, AL Côté, VC de Vries, EJ Usherwood, MJ Turk
Cancer research, 2007AACR
The generation of protective CD8 T-cell memory against tumor-expressed self-antigens is an
important but elusive goal of cancer immunotherapy. The possibility that a progressive,
poorly immunogenic tumor can induce T-cell memory against self-antigens has not
previously been studied. Herein, we report that growth of the poorly immunogenic B16
melanoma in the absence of regulatory T cells (Treg) generates CD8 T-cell responses that
develop into functional memory after the tumor has been surgically excised. Tumor-primed …
Abstract
The generation of protective CD8 T-cell memory against tumor-expressed self-antigens is an important but elusive goal of cancer immunotherapy. The possibility that a progressive, poorly immunogenic tumor can induce T-cell memory against self-antigens has not previously been studied. Herein, we report that growth of the poorly immunogenic B16 melanoma in the absence of regulatory T cells (Treg) generates CD8 T-cell responses that develop into functional memory after the tumor has been surgically excised. Tumor-primed memory T cells recognized melanocyte differentiation antigens TRP-2/DCT and gp100 and persisted for as long as 5 months following surgical tumor excision. Phenotypic analysis showed that these cells develop into both central and effector memory T-cell subsets, which produce IFN-γ and interleukin-2 on reencounter with antigen. Most importantly, tumor-primed memory T cells mediated the rejection of intradermal and systemically disseminated challenge tumors given 30 to 60 days following surgery. Tumor-excised mice also developed autoimmune vitiligo, showing that Treg cells prevent tissue-specific autoimmunity in tumor-bearing hosts. This study establishes that Treg depletion in tumor-bearing hosts drives the natural development of protective T-cell memory. Generating such responses may aid in the clinical management of tumor recurrence and metastasis following surgery. [Cancer Res 2007;67(13):6468–76]
AACR